Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 2/20 | 0.49 |
| ▸ | GRM5 | P41594 | 2/20 | 0.36 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.33 |
| ▸ | CCR1 | P32246 | 3/20 | 0.33 |
| ▸ | CCR8 | P51685 | 3/20 | 0.33 |
| ▸ | CCR5 | P51681 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.32 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.32 |
| ▸ | MET | P08581 | 1/20 | 0.31 |
| ▸ | PTAFR | P25105 | 1/20 | 0.31 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | GMNN | O75496 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27613500 | 0.76 | CYP2A6 (0.50) | CYP2A6PDK1CCR1CCR8CCR5 | |
| SCHEMBL4807743 | 0.75 | GRM5 (0.60) | CYP2A6GRM5PTAFR | |
| SCHEMBL27718541 | 0.71 | HPGDS (0.35) | HTT | |
| SCHEMBL12434 | 0.70 | CYP2A6 (0.55) | CYP2A6PDK1CCR1CCR8CCR5 | |
| SCHEMBL7021081 | 0.69 | CYP2A6 (0.68) | CYP2A6POLBALDH1A1AKR1B1MET | |
| SCHEMBL13909528 | 0.67 | CYP2A6 (0.56) | CYP2A6PDK1CCR1CCR8CCR5 | |
| SCHEMBL12613816 | 0.67 | CYP2A6 (0.51) | CYP2A6PDK1CCR1CCR8CCR5 | |
| SCHEMBL15966332 | 0.67 | CCR1 (0.34) | CYP2A6GRM5CCR1CCR8CCR5 | |
| SCHEMBL12279308 | 0.67 | GRM5 (0.32) | GRM5 | |
| SCHEMBL24611854 | 0.66 | CYP2A6 (0.55) | CYP2A6PDK1CCR1CCR8CCR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070082880-A1 | Thieno [2,3-B] pyridine-5-carbonitriles as protein kinase inhibitors | WYETH | 2007-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070082880-A1 | Thieno [2,3-B] pyridine-5-carbonitriles as protein kinase inhibitors | MAP4K2, CNKSR1, MAP3K1 | CYP2A6 2462/4885GRM5 3123/4885PDK1 297/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.